NASDAQ
07.08.26 | 21:59
15,490 US-Dollar
-0,06 % -0,010
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BRAINSWAY Aktie jetzt für 0€ handeln | |||||
| 29.07. | BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026 | 3 | GlobeNewswire (USA) | ||
| 24.07. | H.C. Wainwright bestätigt Kaufempfehlung für Brainsway nach strategischen Investitionen | 1 | Investing.com Deutsch | ||
| 24.07. | H.C. Wainwright reiterates Brainsway stock rating on strategic investments | 2 | Investing.com | ||
| 20.07. | BrainsWay makes $3M minority investment in Radial Health | 1 | Seeking Alpha | ||
| 20.07. | BrainsWay beteiligt sich mit 3 Millionen US-Dollar an Radial Health | 1 | Investing.com Deutsch | ||
| 20.07. | BrainsWay invests $3 million in Radial Health network | 3 | Investing.com | ||
| 20.07. | BrainsWay Announces Strategic Investment in Radial Health, Inc. | 982 | GlobeNewswire (Europe) | BURLINGTON, Mass. and JERUSALEM, July 20, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive brain stimulation technologies... ► Artikel lesen | |
| 20.07. | BTIG initiates Brainsway stock with buy rating on TMS growth outlook | 4 | Investing.com | ||
| 17.07. | Brainsway stock rating reiterated at Buy by H.C. Wainwright | 1 | Investing.com | ||
| 17.07. | Brainsway stock price target reiterated at $14 by H.C. Wainwright | 2 | Investing.com | ||
| 17.07. | H.C. Wainwright bestätigt Kursziel für Brainsway Aktie bei 14 US-Dollar | 1 | Investing.com Deutsch | ||
| 17.07. | H.C. Wainwright bestätigt Kaufempfehlung für Brainsway | 1 | Investing.com Deutsch | ||
| 16.07. | Brainsway Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.07. | BrainsWay Announces Minority-Stake Investment in Sound Minds Behavioral | 215 | GlobeNewswire (Europe) | BURLINGTON, Mass. and JERUSALEM, July 16, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments... ► Artikel lesen | |
| 02.07. | Brainsway stock rating reiterated at Buy by H.C. Wainwright on PTSD data | 1 | Investing.com | ||
| 29.06. | BrainsWay reports study results on PTSD and depression treatment | 3 | Investing.com | ||
| 29.06. | BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS in Patients with Comorbid PTSD and Major Depressive Disorder | 1 | GlobeNewswire (USA) | ||
| 29.06. | Brainsway Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 23.06. | Brainsway stock price target reiterated at $17 by H.C. Wainwright | 1 | Investing.com | ||
| 22.06. | BrainsWay expands U.S. insurance coverage for depression treatment | 1 | Investing.com |
1 2 3 4 Weiter >>
75 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 6,198 | +0,55 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,020 | -1,94 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| BUTTERFLY NETWORK | 7,600 | -0,55 % | BFLY Q2 Earnings Call Spotlights Embedded Growth and Raised Outlook | ||
| BEYOND AIR | 5,625 | +4,94 % | Beyond Air erfüllt nach Reverse Split wieder Nasdaq-Anforderungen | ||
| AXOGEN | 38,760 | -3,41 % | Axogen, Inc. Reports Second Quarter 2026 Financial Results | ALACHUA, Fla. and TAMPA, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| AETHLON MEDICAL | - | - | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA0813793076 Lightning Resource Corp. 03.08.2026 CA5319651017 Lightning Resource Corp. 04.08.2026 Tausch 1:1CA7857133069 Sable... ► Artikel lesen | |
| AVANOS MEDICAL | 21,600 | 0,00 % | AVANOS MEDICAL, INC. - 15-12G, Securities registration termination | ||
| APYX MEDICAL | 3,480 | -1,14 % | Apyx Medical Corporation Reports Second Quarter 2026 Financial Results | Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece... ► Artikel lesen | |
| ANGIODYNAMICS | 13,000 | -4,41 % | H.C. Wainwright raises AngioDynamics stock price target on growth | ||
| ANTERIS TECHNOLOGIES GLOBAL | 8,920 | +0,11 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Statement of CDIs on issue - AVR | ||
| ADAPTHEALTH | 5,680 | -0,18 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 9,970 | -0,70 % | Morning Market Movers: Gran Tierra Energy, Autonomix Medical, Julong Holding, Shopify See Big Swings | OTTAWA (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 1,060 | -0,93 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study | ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today... ► Artikel lesen | |
| AGAPE ATP | 2,670 | +1,52 % | Morning Market Movers: Intercont (Cayman), Agape ATP, Astrotech, Snowflake See Big Swings | TOKYO (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BONE BIOLOGICS | 0,915 | -1,88 % | BONE BIOLOGICS CORPORATION: Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities | BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics" or the "Company"), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen |
Das Unternehmen BRAINSWAY LTD ADR kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,010 (-0,06 %) liegt der Kurs bei 15,490 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRAINSWAY LTD ADR finden Sie auf Wallstreet Online.